CD8A and neoplasm: An in vivo study conducted on orthotopic tumor-bearing C57BL/6 mice injected with MC38 cells indicated enhanced CD8+ T cell infiltration in tumors, thereby arresting tumor growth when combined with mithramycin A and α-PD-L1 blocker.